Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.
Hepatology
; 68(3): 1010-1024, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-29604220
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepatitis C
/
Carcinoma, Hepatocellular
/
Angiopoietin-2
/
Liver Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hepatology
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: